Geode Capital Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.89M | Sell |
|
|||||
|
2025
Q1 | $1.12M | Buy |
|
|||||
|
2024
Q4 | $3.27M | Buy |
|
|||||
|
2024
Q3 | $6.13M | Buy |
|
|||||
|
2024
Q2 | $5.14M | Buy |
|
|||||
|
2024
Q1 | $8.18M | Buy |
|
|||||
|
2023
Q4 | $4.4M | Buy |
|
|||||
|
2023
Q3 | $3.46M | Buy |
|
|||||
|
2023
Q2 | $3.44M | Buy |
|
|||||
|
2023
Q1 | $1.38M | Buy |
|
|||||
|
2022
Q4 | $244K | Sell |
|
|||||
|
2022
Q3 | $626K | Buy |
|
|||||
|
2022
Q2 | $1.03M | Buy |
|
|||||
|
2022
Q1 | $760K | Buy |
|
|||||
|
2021
Q4 | $1.25M | Sell |
|
|||||
|
2021
Q3 | $2.3M | Buy |
|
|||||
|
2021
Q2 | $3.06M | Buy |
|
|||||
|
2021
Q1 | $2.98M | Buy |
|
|||||
|
2020
Q4 | $2.2M | Buy |
|
|||||
|
2020
Q3 | $2.58M | Buy |
|